BIOMONITOR IIIm
Physicians working with ICMs generally have a very heavy workload and false positive AF detections just add to this, as well as making effective diagnosis more difficult.1
BIOMONITOR IIIm provides answers to both of these issues. Minimizing unnecessary work by significantly reducing AF false positives2, and maximizing precision by consistently delivering clear, high definition ECGs. Helping physicians focus on the things that really matter.3
Product Highlights
Minimized Workload
With its breakthrough RhythmCheck algorithm, BIOMONITOR IIIm greatly reduces time-consuming ECG reviews of episodes falsely detected as atrial fibrillation2
Maximized Precision
BIOMONITOR IIIm delivers clinically actionable high-definition ECGs4
Patient-Centered Monitoring Experience
From injection to diagnosis, BIOMONITOR IIIm enhances workflow efficiency in every step of delivering a timely and accurate diagnosis
Media
Downloads & Related Links
Contact Us
References
*The proportion of a 24-hour period, during which very fast signals (<180 ms) prevent the evaluation of the rhythm
1) Seiler A, Biundo E, Di Bacco M, et al. Clinic Time Required for Remote and In-Person Management of Patients With Cardiac Devices: Time and Motion Workflow Evaluation. JMIR Cardio. 2021;5(2):e27720. Published 2021 Oct 15. doi:10.2196/27720 2) Bisignani G, Cheung JW, Rordorf R, et al. Implantable cardiac monitors: artificial intelligence and signal processing reduce remote ECG review workload and preserve arrhythmia detection sensitivity. Front Cardiovasc Med. 2024;11:1343424. Published 2024 Jan 23. doi:10.3389/fcvm.2024.1343424 3) McDowall L et al. The BIO|CONCEPT.BIOMONITOR III study: Performance of implanted BIOMONITOR IIITM for detection of baseline electrocardiogram (ECG) parameters. Poster AP19-01240; APHRS 2019 4) Deneke T, Cabanas P, Hofer D, et al. New-generation miniaturized insertable cardiac monitor with a long sensing vector: Insertion procedure, sensing performance, and home monitoring transmission success in a real-world population. Heart Rhythm O2. 2022;3(2):152-159. Published 2022 Jan 30. doi:10.1016/j.hroo.2022.01.010 5) Performance of BIOMONITOR IIIm Ectopy Rejection Parameter in Patients with Ectopy. BIOTRONIK Data on File; 6) BIO|CONCEPT.BIOMONITOR III. BIOTRONIK Data on file; 7) Mariani JA et al. J Electrocardiol. 2020, 60.; 8) Piorkowski C, et al. Pacing and clinical electrophysiology : PACE. 2019; 9) BIOTRONIK AF Detect Analysis data on file 2019. PPV and sensitivity from analysis of BIOMONITOR III algorithm in patients with known AF from BIOTRONIK AF Detect study; 10) Afzal. Et al. Incidence of false-positive transmissions during remote rhythm monitoring with implantable loop recorders. Heart Rhythm 2020;17:75–80; 11) Assaf A, Theuns DAMJ, Sakhi R, Bhagwandien RE, Szili-Torok T, Yap SC. Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study. Ann Noninvasive Electrocardiol. 2022;27(3):e12960. doi:10.1111/anec.12960; 12) Schreiber T, Cretnik A, Schauerte P, et al. P-wave detection performance of the BioMonitor III, Confirm Rx and Reveal Linq implantable loop recorders. J Electrocardiol. 2022;71:62-66. doi:10.1016/j.jelectrocard.2022.01.005; 13) BIOTRONIK. BIOMONITOR IIIm Technical Manual. MN093r1 12/10/20